DEFB109C
Beta-defensin 109C
Also known as: D109C_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for DEFB109C in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
87 residues, UniProt reviewed canonical sequence.
>P0DY27|DEFB109C
1 MRLHLLLLIL LLFSILLSPV RGGLGPAEGH CLNLFGVCRT DVCNIVEDQI GACRRRMKCC
61 RAWWILMPIP TPLIMSDYQE PLKPNLKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DEFB109C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DEFB109C as an antibody target. Whether an autoantibody or antibody against DEFB109C could matter depends on whether native DEFB109C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DEFB109C is annotated as secreted, so native DEFB109C circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DEFB109C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...